SLC38A11
gene geneOn this page
Also known as FLJ39822AVT2
Summary
SLC38A11 (solute carrier family 38 member 11, HGNC:26836) is a protein-coding gene on chromosome 2q24.3, encoding Putative sodium-coupled neutral amino acid transporter 11 (Q08AI6). Putative sodium-dependent amino acid/proton antiporter.
Predicted to enable L-amino acid transmembrane transporter activity. Predicted to be involved in amino acid transmembrane transport. Predicted to be active in membrane.
Source: NCBI Gene 151258 — RefSeq curated summary.
At a glance
- GWAS associations: 38
- Clinical variants (ClinVar): 77 total — 1 pathogenic
- MANE Select transcript:
NM_001351537
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26836 |
| Approved symbol | SLC38A11 |
| Name | solute carrier family 38 member 11 |
| Location | 2q24.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ39822, AVT2 |
| Ensembl gene | ENSG00000169507 |
| Ensembl biotype | protein_coding |
| OMIM | 616526 |
| Entrez | 151258 |
Gene structure
Transcript identifiers
Ensembl transcripts: 11 — 6 protein_coding, 4 retained_intron, 1 protein_coding_CDS_not_defined
ENST00000303735, ENST00000409058, ENST00000409149, ENST00000409662, ENST00000424914, ENST00000465898, ENST00000470576, ENST00000483641, ENST00000492134, ENST00000493887, ENST00000685975
RefSeq mRNA: 6 — MANE Select: NM_001351537
NM_001199148, NM_001351537, NM_001351538, NM_001351539, NM_001351540, NM_173512
CCDS: CCDS2224, CCDS56142, CCDS92885
Canonical transcript exons
ENST00000685975 — 12 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001130083 | 164939450 | 164939556 |
| ENSE00001130511 | 164911636 | 164911748 |
| ENSE00001582244 | 164944569 | 164944634 |
| ENSE00003478006 | 164954631 | 164954745 |
| ENSE00003517409 | 164937350 | 164937429 |
| ENSE00003531046 | 164945593 | 164945727 |
| ENSE00003567881 | 164915112 | 164915273 |
| ENSE00003628013 | 164915903 | 164915973 |
| ENSE00003672515 | 164908640 | 164908771 |
| ENSE00003928844 | 164955209 | 164955525 |
| ENSE00003932117 | 164952707 | 164952781 |
| ENSE00003934453 | 164894354 | 164898730 |
Expression profiles
Bgee: expression breadth ubiquitous, 185 present calls, max score 94.98.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.7837 / max 90.9503, expressed in 177 samples.
FANTOM5 promoters (6 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 31645 | 0.2395 | 100 |
| 31644 | 0.2213 | 99 |
| 31643 | 0.1263 | 41 |
| 31642 | 0.0798 | 38 |
| 31647 | 0.0592 | 23 |
| 31646 | 0.0577 | 29 |
Top tissues by expression
250 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| corpus epididymis | UBERON:0004359 | 94.98 | gold quality |
| gall bladder | UBERON:0002110 | 91.68 | gold quality |
| pancreatic ductal cell | CL:0002079 | 91.22 | gold quality |
| metanephros cortex | UBERON:0010533 | 89.60 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 87.82 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 85.95 | silver quality |
| primary visual cortex | UBERON:0002436 | 85.80 | gold quality |
| spleen | UBERON:0002106 | 81.86 | gold quality |
| right frontal lobe | UBERON:0002810 | 81.20 | gold quality |
| caput epididymis | UBERON:0004358 | 81.14 | gold quality |
| body of stomach | UBERON:0001161 | 80.88 | gold quality |
| endothelial cell | CL:0000115 | 79.83 | silver quality |
| middle temporal gyrus | UBERON:0002771 | 79.70 | gold quality |
| occipital lobe | UBERON:0002021 | 79.56 | gold quality |
| stomach | UBERON:0000945 | 79.17 | gold quality |
| putamen | UBERON:0001874 | 77.77 | gold quality |
| prostate gland | UBERON:0002367 | 77.71 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 76.97 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 76.96 | gold quality |
| cauda epididymis | UBERON:0004360 | 76.90 | gold quality |
| seminal vesicle | UBERON:0000998 | 76.74 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 76.47 | gold quality |
| retina | UBERON:0000966 | 76.46 | gold quality |
| adenohypophysis | UBERON:0002196 | 76.04 | gold quality |
| caudate nucleus | UBERON:0001873 | 75.88 | gold quality |
| body of pancreas | UBERON:0001150 | 75.75 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 75.74 | gold quality |
| amygdala | UBERON:0001876 | 75.31 | gold quality |
| rectum | UBERON:0001052 | 74.98 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 74.98 | gold quality |
Single-cell (SCXA)
Detected in 4 experiment(s), a significant marker in 4.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-8495 | yes | 531.86 |
| E-HCAD-35 | yes | 8.29 |
| E-ANND-3 | yes | 6.93 |
| E-GEOD-125970 | yes | 5.13 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): CLDN19, CLDN3
miRNA regulators (miRDB)
26 targeting SLC38A11, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-181A-5P | 99.99 | 72.96 | 2995 |
| HSA-MIR-181B-5P | 99.99 | 72.97 | 2996 |
| HSA-MIR-181C-5P | 99.99 | 72.95 | 2996 |
| HSA-MIR-181D-5P | 99.99 | 73.04 | 2997 |
| HSA-MIR-4803 | 99.98 | 71.99 | 3117 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-32-5P | 99.98 | 75.21 | 1964 |
| HSA-MIR-92A-3P | 99.98 | 75.21 | 1960 |
| HSA-MIR-92B-3P | 99.98 | 75.25 | 1955 |
| HSA-MIR-25-3P | 99.98 | 74.60 | 1817 |
| HSA-MIR-363-3P | 99.98 | 74.72 | 1821 |
| HSA-MIR-367-3P | 99.98 | 74.83 | 1819 |
| HSA-MIR-570-3P | 99.96 | 72.41 | 4910 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-145-5P | 99.92 | 71.13 | 1836 |
| HSA-MIR-5195-3P | 99.92 | 70.92 | 1877 |
| HSA-MIR-627-3P | 99.90 | 71.42 | 3316 |
| HSA-MIR-548E-5P | 99.89 | 72.73 | 4486 |
| HSA-MIR-6083 | 99.47 | 68.73 | 2393 |
| HSA-MIR-4480 | 99.42 | 66.02 | 735 |
| HSA-MIR-410-3P | 99.27 | 69.98 | 2457 |
| HSA-MIR-6739-3P | 99.22 | 68.84 | 1843 |
| HSA-MIR-375-3P | 97.91 | 65.12 | 483 |
| HSA-MIR-3691-3P | 97.90 | 65.97 | 791 |
Cross-species orthologs
10 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | slc38a11 | ENSDARG00000040257 |
| mus_musculus | Slc38a11 | ENSMUSG00000061171 |
| rattus_norvegicus | Slc38a11 | ENSRNOG00000004966 |
| drosophila_melanogaster | CG13743 | FBGN0033368 |
| caenorhabditis_elegans | slc-36.4 | WBGENE00010421 |
| caenorhabditis_elegans | Y18D10A.23 | WBGENE00012487 |
| caenorhabditis_elegans | WBGENE00012629 | |
| caenorhabditis_elegans | WBGENE00012804 | |
| caenorhabditis_elegans | WBGENE00019837 | |
| caenorhabditis_elegans | WBGENE00020837 |
Paralogs (15): SLC38A5 (ENSG00000017483), SLC32A1 (ENSG00000101438), SLC38A7 (ENSG00000103042), SLC38A1 (ENSG00000111371), SLC36A1 (ENSG00000123643), SLC38A2 (ENSG00000134294), SLC38A4 (ENSG00000139209), SLC38A6 (ENSG00000139974), SLC38A10 (ENSG00000157637), SLC38A8 (ENSG00000166558), SLC38A9 (ENSG00000177058), SLC36A4 (ENSG00000180773), SLC36A3 (ENSG00000186334), SLC36A2 (ENSG00000186335), SLC38A3 (ENSG00000188338)
Protein
Protein identifiers
Putative sodium-coupled neutral amino acid transporter 11 — Q08AI6 (reviewed: Q08AI6)
Alternative names: Solute carrier family 38 member 11
All UniProt accessions (4): A0A8I5QKK7, B8ZZ86, Q08AI6, H7C1P1
UniProt curated annotations — full annotation on UniProt →
Function. Putative sodium-dependent amino acid/proton antiporter.
Subcellular location. Membrane.
Similarity. Belongs to the amino acid/polyamine transporter 2 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q08AI6-1 | 1 | yes |
| Q08AI6-2 | 2 |
RefSeq proteins (6): NP_001186077, NP_001338466, NP_001338467, NP_001338468, NP_001338469, NP_775783 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR013057 | AA_transpt_TM | Domain |
Pfam: PF01490
UniProt features (16 total): transmembrane region 10, glycosylation site 2, chain 1, topological domain 1, splice variant 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q08AI6-F1 | 88.50 | 0.74 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (2): 44, 275
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 71 (showing top):
GOBP_AMINO_ACID_TRANSMEMBRANE_TRANSPORT, GOBP_MONOATOMIC_CATION_TRANSPORT, GOBP_ORGANIC_ACID_TRANSPORT, chr2q24, GOBP_AMINO_ACID_TRANSPORT, GOBP_ORGANIC_ANION_TRANSPORT, HAND1E47_01, LINDVALL_IMMORTALIZED_BY_TERT_UP, GOBP_TRANSMEMBRANE_TRANSPORT, GOBP_SODIUM_ION_TRANSPORT, GOMF_L_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, GOMF_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, GOMF_TRANSPORTER_ACTIVITY, MIKKELSEN_MEF_ICP_WITH_H3K27ME3, RATTENBACHER_BOUND_BY_CELF1
GO Biological Process (5): amino acid transmembrane transport (GO:0003333), sodium ion transport (GO:0006814), monoatomic ion transport (GO:0006811), amino acid transport (GO:0006865), L-alpha-amino acid transmembrane transport (GO:1902475)
GO Molecular Function (2): L-amino acid transmembrane transporter activity (GO:0015179), protein binding (GO:0005515)
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transport | 2 |
| amino acid transport | 1 |
| transmembrane transport | 1 |
| metal ion transport | 1 |
| amino acid transmembrane transport | 1 |
| L-amino acid transport | 1 |
| carboxylic acid transmembrane transport | 1 |
| amino acid transmembrane transporter activity | 1 |
| carboxylic acid transmembrane transporter activity | 1 |
| L-alpha-amino acid transmembrane transport | 1 |
| binding | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
543 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SLC38A11 | REELD1 | A0A1B0GV85 | 595 |
| SLC38A11 | SLC38A9 | Q8NBW4 | 560 |
| SLC38A11 | C16orf96 | A6NNT2 | 551 |
| SLC38A11 | ZNF142 | P52746 | 460 |
| SLC38A11 | SLC7A4 | O43246 | 452 |
| SLC38A11 | SLC43A2 | Q8N370 | 433 |
| SLC38A11 | COBLL1 | Q53SF7 | 419 |
| SLC38A11 | SLC6A15 | Q9H2J7 | 381 |
| SLC38A11 | GLB1L | Q6UWU2 | 380 |
| SLC38A11 | CSRNP3 | Q8WYN3 | 374 |
| SLC38A11 | KRTAP19-1 | Q8IUB9 | 366 |
| SLC38A11 | GJD4 | Q96KN9 | 364 |
| SLC38A11 | SLC3A1 | Q07837 | 360 |
| SLC38A11 | SLC38A10 | Q9HBR0 | 355 |
| SLC38A11 | SLC7A8 | Q9UHI5 | 351 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TUSC5 | SLC38A11 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TUSC5 | SLC38A11 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (2): TUSC5 (Two-hybrid), SLC38A11 (Affinity Capture-MS)
ESM2 similar proteins: A1YG32, A2VCW5, A2VE31, D3Z813, F4KBM7, G3UVW3, O80668, P38176, P39981, P40074, P40501, P47082, Q08AI6, Q0WQJ3, Q17598, Q19425, Q28HE5, Q28I47, Q3U1J0, Q3USY0, Q503G8, Q54S12, Q5E9S9, Q5EA97, Q5F468, Q5R443, Q5RE87, Q5SPB1, Q5XH90, Q610N4, Q6DEL1, Q6DFE7, Q6WWW3, Q8CFE6, Q8HXI3, Q8IZM9, Q8K2P7, Q8R1S9, Q8WUX1, Q969I6
Diamond homologs: A8KBL5, D3Z813, P39981, Q08AI6, Q3USY0, Q5EA97, Q5RE87, Q8HXI3, Q969I6, P38176, P40074, P40501
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
77 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 64 |
| Likely benign | 2 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 1526927 | GRCh37/hg19 2q24.2-24.3(chr2:163168812-167567296) | Pathogenic |
SpliceAI
2222 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:164908632:GTAC:G | donor_loss | 1.0000 |
| 2:164908633:TAC:T | donor_loss | 1.0000 |
| 2:164908634:A:AC | donor_gain | 1.0000 |
| 2:164908634:AC:A | donor_loss | 1.0000 |
| 2:164908635:C:CC | donor_gain | 1.0000 |
| 2:164908635:CTCA:C | donor_gain | 1.0000 |
| 2:164908636:TCA:T | donor_loss | 1.0000 |
| 2:164908637:C:CC | donor_loss | 1.0000 |
| 2:164908638:A:AC | donor_gain | 1.0000 |
| 2:164908638:A:C | donor_loss | 1.0000 |
| 2:164908639:C:CC | donor_gain | 1.0000 |
| 2:164908639:C:CG | donor_loss | 1.0000 |
| 2:164908639:CA:C | donor_gain | 1.0000 |
| 2:164908639:CATTG:C | donor_gain | 1.0000 |
| 2:164915213:G:C | donor_gain | 1.0000 |
| 2:164915894:AATAC:A | donor_loss | 1.0000 |
| 2:164915895:ATACT:A | donor_loss | 1.0000 |
| 2:164915896:TACTC:T | donor_loss | 1.0000 |
| 2:164915897:AC:A | donor_loss | 1.0000 |
| 2:164915898:C:CG | donor_loss | 1.0000 |
| 2:164915899:T:TC | donor_loss | 1.0000 |
| 2:164915900:CA:C | donor_loss | 1.0000 |
| 2:164915901:A:C | donor_loss | 1.0000 |
| 2:164915974:C:CC | acceptor_gain | 1.0000 |
| 2:164937344:A:C | donor_gain | 1.0000 |
| 2:164937344:ACTT:A | donor_loss | 1.0000 |
| 2:164937345:CTT:C | donor_loss | 1.0000 |
| 2:164937346:TTA:T | donor_loss | 1.0000 |
| 2:164937348:A:AC | donor_gain | 1.0000 |
| 2:164937348:ACATG:A | donor_loss | 1.0000 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000031962 (2:164905055 G>T), RS1000090344 (2:164956934 A>G), RS1000120145 (2:164956740 TGAC>T), RS1000173879 (2:164912361 T>C), RS1000321133 (2:164949556 T>A,C), RS1000325395 (2:164950606 G>T), RS1000373365 (2:164949774 G>C), RS1000380627 (2:164937401 G>A), RS1000438262 (2:164910874 C>T), RS1000494287 (2:164912330 T>A), RS1000568363 (2:164925578 A>G), RS1000599306 (2:164925877 C>G), RS1000751577 (2:164905370 G>A), RS1000758625 (2:164911975 T>C), RS1000812456 (2:164942384 A>G)
Disease associations
OMIM: gene MIM:616526 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
38 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002579_8 | Heschl’s gyrus morphology | 2.000000e-06 |
| GCST005950_14 | Body mass index x sex x age interaction (4df test) | 4.000000e-07 |
| GCST005951_55 | Body mass index | 3.000000e-06 |
| GCST005952_7 | Body mass index (age>50) | 4.000000e-09 |
| GCST005956_34 | Waist-to-hip ratio adjusted for BMI | 2.000000e-13 |
| GCST005957_2 | Waist-to-hip ratio adjusted for BMI (age <50) | 1.000000e-16 |
| GCST005958_3 | Waist-to-hip ratio adjusted for BMI (age >50) | 1.000000e-16 |
| GCST005962_14 | Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test) | 1.000000e-29 |
| GCST011687_2 | Systolic blood pressure | 6.000000e-07 |
| GCST90020024_1152 | A body shape index | 2.000000e-12 |
| GCST90020024_1153 | A body shape index | 2.000000e-11 |
| GCST90020024_1154 | A body shape index | 7.000000e-09 |
| GCST90020025_1719 | Waist-to-hip ratio adjusted for BMI | 4.000000e-14 |
| GCST90020025_1724 | Waist-to-hip ratio adjusted for BMI | 1.000000e-21 |
| GCST90020025_1725 | Waist-to-hip ratio adjusted for BMI | 2.000000e-19 |
| GCST90020025_1726 | Waist-to-hip ratio adjusted for BMI | 4.000000e-15 |
| GCST90020025_1727 | Waist-to-hip ratio adjusted for BMI | 5.000000e-08 |
| GCST90020025_1728 | Waist-to-hip ratio adjusted for BMI | 7.000000e-10 |
| GCST90020025_1729 | Waist-to-hip ratio adjusted for BMI | 1.000000e-11 |
| GCST90020025_1730 | Waist-to-hip ratio adjusted for BMI | 1.000000e-09 |
| GCST90020025_1731 | Waist-to-hip ratio adjusted for BMI | 1.000000e-10 |
| GCST90020026_366 | Hip index | 3.000000e-10 |
| GCST90020026_367 | Hip index | 5.000000e-09 |
| GCST90020026_368 | Hip index | 1.000000e-09 |
| GCST90020027_566 | Waist-hip index | 2.000000e-13 |
| GCST90020027_571 | Waist-hip index | 1.000000e-21 |
| GCST90020027_572 | Waist-hip index | 7.000000e-20 |
| GCST90020027_573 | Waist-hip index | 7.000000e-15 |
| GCST90020027_574 | Waist-hip index | 3.000000e-08 |
| GCST90020027_575 | Waist-hip index | 4.000000e-08 |
EFO canonical traits (7, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004340 | body mass index |
| EFO:0008007 | age at assessment |
| EFO:0008343 | sex interaction measurement |
| EFO:0007788 | BMI-adjusted waist-hip ratio |
| EFO:0006335 | systolic blood pressure |
| EFO:0007789 | BMI-adjusted waist circumference |
| EFO:0008039 | BMI-adjusted hip circumference |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: transporter — Orphan SLC38 transporters
CTD chemical–gene interactions
18 total (human), top 18 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | decreases expression, decreases methylation | 4 |
| Cyclosporine | decreases expression | 3 |
| Estradiol | decreases expression, affects expression | 2 |
| Tetrachlorodibenzodioxin | decreases expression | 2 |
| Aflatoxin B1 | affects expression, decreases expression | 2 |
| mivebresib | decreases expression | 1 |
| fluorene-9-bisphenol | increases expression | 1 |
| methyleugenol | decreases expression | 1 |
| tris(2-butoxyethyl) phosphate | affects expression | 1 |
| 2,6-dichloro-(1,4)benzoquinone | increases expression | 1 |
| Vorinostat | decreases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Amiodarone | increases expression | 1 |
| Azathioprine | decreases expression | 1 |
| Quercetin | decreases expression | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_D4TE | HuH7-SLC38A11-KO-c4 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.